Successful Laser Treatment of Vandetanib-Associated Cutaneous Pigmentation
- 1 March 2011
- journal article
- other
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 147 (3) , 364-365
Abstract
Several patterns of cutaneous hyperpigmentation in patients receiving the multikinase inhibitor vandetanib (ZD6474) were recently described. We describe hereinKeywords
This publication has 4 references indexed in Scilit:
- Cutaneous Pigmentation After Photosensitivity Induced by Vandetanib TherapyArchives of Dermatology, 2009
- Minocycline-Induced Hyperpigmentation Treated with a 755-nm Q-Switched Alexandrite LaserDermatologic Surgery, 2004
- Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literatureJournal of the American Academy of Dermatology, 2001
- Treatment of Minocycline-Induced Hyperpigmentation With the Q-Switched Ruby LaserArchives of Dermatology, 1996